Cargando…
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors
Muscle invasive bladder cancer (MIBC) is a widespread malignancy with a worse prognosis often related to a late diagnosis. For early-stage MIBC pts, a multidisciplinary approach is mandatory to evaluate the timing of neoadjuvant chemotherapy (NAC) and surgery. The current standard therapy is platinu...
Autores principales: | Iacovino, Maria Lucia, Miceli, Chiara Carmen, De Felice, Marco, Barone, Biagio, Pompella, Luca, Chiancone, Francesco, Di Zazzo, Erika, Tirino, Giuseppe, Della Corte, Carminia Maria, Imbimbo, Ciro, De Vita, Ferdinando, Crocetto, Felice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835066/ https://www.ncbi.nlm.nih.gov/pubmed/35163064 http://dx.doi.org/10.3390/ijms23031133 |
Ejemplares similares
-
The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications
por: Torabinejad, Sepehr, et al.
Publicado: (2023) -
Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
por: Ferro, Matteo, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
por: Barone, Biagio, et al.
Publicado: (2022) -
Granulomatous prostatitis mimicking prostate cancer in a patient with
psoriatic arthritis: a case report
por: De Luca, Luigi, et al.
Publicado: (2020) -
A case of incidentally discovered solitary fibrous tumor of the kidney: A case study
por: De Luca, Luigi, et al.
Publicado: (2020)